Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $449.4M | $813.9M | ($1,190.0M) | $1,615.3M | $2,011.2M | $2,635.8M | $2,901.3M | $2,803.6M | $2,591.6M | $3,074.8M | $12.1B | $18.1B | $13.5B | $4,628.0M | $5,455.0M | $5,386.0M | $89.0M | $6,225.0M | $4,592.0M | $5,665.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Gilead Sciences, Inc.'s last 12-month Net Income is $126.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Gilead Sciences, Inc.'s Net Income growth was (97.9%). The average annual Net Income growth rates for Gilead Sciences, Inc. have been (25.2%) over the past three years, (45.8%) over the past five years.
Over the last year, Gilead Sciences, Inc.'s Net Income growth was (97.9%), which is lower than industry growth of (0.3%). It indicates that Gilead Sciences, Inc.'s Net Income growth is Bad.